1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32 | -R10 did not receive their 5:00 pm: Aspirin 81mg, Atorvastatin Calcium 40mg
-R11 did not receive their 5:00 pm: Flecainide Acetate 100mg, Atorvastatin Calcium 20mg, Triamcinolone Acetonide 0.1% cream
-R12 did not receive their 5:00 pm: Hydrocodone 5mg, Famotidine 20mg; 5:30 pm: Senna 8.6mg; 8:00 pm: Trazadone HCL 50mg
The incident reports indicate resident’s physicians were contacted on 07/17/2024, after the discrepancies were discovered. Additionally, all affected residents were placed on alert charting for 48 hours after the discovery.
The IR states S2 was terminated from the facility, and other med techs were to receive ongoing training to review policies and procedures for medications. LPA discussed the importance of accurate assistance with medication with the new Administrator.
Additionally, on 08/28/2024, 08/29/2024, and 9/5/2024, LPA reviewed three incident reports for R13 that indicated R13 had multiple private caregivers. The private caregivers had fingerprint clearance but were not associated to the facility.
Additionally, record review and interviews conducted revealed the facility contracts with an outside home health agency for additional staffing when needed as well as 1:1 for private care. Records reviewed revealed 10 temporary staff members had fingerprint clearance but were not associated to the facility.
The following deficiencies were observed (See LIC 809-D.) and cited from the CA Code of Regulations, Title 22 Regulations. Civil penalty assessed for criminal record clearance transfer violation.
Exit interview conducted. A copy of the report and civil penalties was issued at the time of the visit along with appeal rights.
|